Published data from cagrilintide research specifically demonstrates reductions in relative fat mass while maintaining relative lean mass
Side effects were more common in the oral semaglutide group (16.7%) than in the injection group (4.9%)
Here is a side-by-side comparison based on available trial data: Semaglutide 2.4 mg (Wegovy): 14.9% average weight loss over 68 weeks, GLP-1 receptor agonist only Tirzepatide 15 mg (Zepbound/Mounjaro): 20.9% average weight loss over 72 weeks, dual GLP-1 and GIP agonist Retatrutide 12 mg: 24.2% average weight loss over 48 weeks, triple GLP-1, GIP, and glucagon agonist What I found interesting in the data is that retatrutide appears to produce faster early weight loss than either semaglutide or tirzepatide
This peptide hormone is well known for its mediative effect in regulating cellular glucose transport in the periphery and has been demonstrated to cross the BBB through insulin transporters [128] to act on insulin receptors which are widespread throughout the brain, localized on neurons, astrocytes, and microglia [129,130,131]
Factors That Affect Retatrutide Dosage Everyones body is different, and a few factors can affect the retatrutide dosage youll need: Your weight : Heavier individuals may start at a slightly higher dose
Some individuals may achieve even greater results
